Loading organizations...
Key people at ACXIT Capital Partners.
ACXIT Capital Partners is a corporate finance advisory and private equity firm based in Frankfurt, Germany, that provides mergers and acquisitions, capital markets, and restructuring services to European middle-market companies. The organization focuses on high-growth sectors such as technology, healthcare, internet, media, and real estate, generating revenue through advisory fees, retainers, and success-based commissions on completed deals. Prior to its acquisition, the firm employed approximately 50 investment banking professionals and had completed nearly 500 financial transactions across its international offices. In July 2022, the firm was acquired by the American multinational investment bank Stifel Financial Corp, integrating its operations alongside key executives like Thomas Klack and Jens Tschauder into the broader DACH advisory platform. Following a 2015 merger with Corporate Finance Partners, ACXIT Capital Partners traces its origins to its founding in 1998 by Johannes H. Lucas.
Key people at ACXIT Capital Partners.
ACXIT Capital Partners was a leading international corporate finance and investment advisory firm specializing in mid-market clients and entrepreneurs across Europe and beyond.[1][2] Its mission centered on delivering advisory services in mergers & acquisitions (M&A), capital markets, debt advisory, restructuring, and strategic solutions, particularly for emerging companies in high-growth sectors like healthcare, technology, software & IT, internet & media, mobility, mobile & telecom, retail & consumer goods, real estate, and industrials.[2][3][5] With a team of about 50 professionals operating from offices in Frankfurt, Zurich, and Munich, ACXIT completed nearly 500 transactions since 1999, playing a key role in the startup and mid-market ecosystem by providing capital access and deal-making expertise to fuel growth in these dynamic verticals.[2]
The firm was acquired by Stifel Financial Corp. in a definitive agreement announced in 2022, with the deal closing around July 1, 2022, enhancing Stifel's European presence and leadership in sectors like healthcare.[2][3][4][7]
Founded in 1999 in Frankfurt, Germany, ACXIT Capital Partners emerged as an independent boutique firm focused on corporate finance for mid-market players.[2][3] Key details on founding partners are not specified in available sources, but the firm quickly built a reputation through its dedicated team, growing to around 50 professionals across Frankfurt (headquarters), Zurich, and Munich.[2][7] Its evolution centered on expanding advisory services amid Europe's mid-market boom, completing nearly 500 deals in M&A, capital raises, and restructurings while honing a focus on high-growth areas like tech and healthcare.[2] This trajectory culminated in its 2022 acquisition by Stifel Financial Corp., a U.S.-based financial services giant, which integrated ACXIT's European expertise into its global platform.[2][3][4][7]
ACXIT rode the wave of Europe's mid-market consolidation and high-growth tech expansion, particularly in healthcare and technology, where demand for M&A and capital advisory surged amid digital transformation and post-pandemic recovery.[2][3] Its timing was ideal: founded in 1999 during the dot-com era and scaling through the 2010s tech boom, it capitalized on market forces like rising SaaS adoption, mobility innovations, and healthcare digitization, facilitating deals for startups and scale-ups in these sectors.[2][5] By bridging entrepreneurs with capital in fragmented European markets, ACXIT influenced the ecosystem through nearly 500 transactions, enabling growth in software, IT, and media—though its 2022 acquisition by Stifel amplified this impact by embedding its expertise into a larger global network.[2][3][4]
Post-acquisition, ACXIT operates as part of Stifel Financial, likely expanding its deal flow through Stifel's resources and U.S.-Europe synergies, with strengthened healthcare leadership.[2][3][7] Trends like AI-driven tech M&A, sustainable mobility, and pharma innovation will shape its path, positioning it to handle more cross-border transactions in a volatile economic climate. Its influence may evolve from boutique advisor to integrated powerhouse, driving mid-market liquidity in Europe's tech ecosystem—echoing its origins as a 1999-founded deal engine now scaled globally.[2][4]
